Anticorps Polyclonal de lapin anti-ARHGAP44

ARHGAP44 Polyclonal Antibody for WB, IF/ICC, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IF/ICC, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 32382-1-PBS

Synonymes

KIAA0672, NPC-A-10, Rho GTPase Activating Protein 44, Rho GTPase-activating protein 44, Rho GTPase-Activating Protein RICH2



Informations sur le produit

32382-1-PBS cible ARHGAP44 dans les applications de WB, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène ARHGAP44 Protéine recombinante Ag38196
Nom complet Rho-type GTPase-activating protein RICH2
Masse moléculaire calculée818aa, 89 kDa
Poids moléculaire observé80-100 kDa
Numéro d’acquisition GenBankNM_001321166
Symbole du gène RICH2
Identification du gène (NCBI) 9912
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Rho GTPase-activating protein 44 (ARHGAP44) belongs to the Rho GTPase-activating protein (RhoGAP) family, also known as Rich2.ARHGAP44 plays an important role in cytoskeletal dynamics, cellular motility and signaling. Its high expression in osteosarcoma correlates with tumor malignancy, suggesting its potential as a potential therapeutic target. In addition, ARHGAP44 may also be involved in the pathogenesis of diabetes and cardiovascular diseases, and its specific role in these diseases needs to be further investigated in the future.

{{ptg:RelatedPrimaryAntibodies}}